Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular N-acetylcysteine versus triamcinolone hexacetonide for knee and hip osteoarthritis
RBR-4nvxt7xPhase 3Recruiting
- Sponsor
- Santa Casa de Misericórdia de Belo Horizonte
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of acetylcysteine and triamcinolone hexacetonide in knee osteoarthritis (OA) and hip osteoarthritis (2 arms), sponsored by Santa Casa de Misericórdia de Belo Horizonte. Started Jun 2023; status: recruiting.
02
Drugs
acetylcysteinetriamcinolone hexacetonide
03
Conditions
knee osteoarthritis (OA)hip osteoarthritis
Beyond the preview
Go deeper on RBR-4nvxt7x.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4nvxt7x.